This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas C. Quinn, MD

JAMA. 1985;253(2):247-249.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the relatively short span of three years, over 7,000 cases of the acquired immunodeficiency syndrome (AIDS) have been diagnosed in the United States² Preliminary surveillance reports also estimate over 500 cases in the rest of the Americas, 600 in Europe, and several thousand cases in central Africa.³ With a mortality rate that, two years from diagnosis, exceeds 80%, this illness now ranks as one of the most serious epidemics confronting man in modern time.

Medical scientists were recently rewarded with the recovery of a type C human retrovirus from AIDS patients and patients with prodromal signs and symptoms of AIDS.^4,5 While this retrovirus, referred to as "human T-cell lymphotropic virus" (HTLV-III) or "lymphadenopathy-associated virus" (LAV), has not been definitively proved to be the etiologic agent of AIDS, all available evidence strongly supports its causal role. The virus has been cultured from lymphocytes, lymph nodes, semen, and saliva . . . [Full Text PDF of this Article]

Author Affiliations
National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Md

Footnotes
Address editorial communications to the Editor, 535 N Dearborn St, Chicago, IL 60610.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?